The German Cabinet of Health adopted today (10 July) the draft of a new “digital supply law” that aims to improve access to digital health care across the country. The new law will, for instance, enable doctors to prescribe health apps that allow patients to… read more
The European Commission is calling the European Committee for Standardization (CEN) and the European Committee for Electrotechnical Standardization (CENELEC) to propose revision to current standards and new ones to be in line with the coming Medical Devices and In Vitro Diagnostics Regulations’ requirements. The requested… read more
In a public statement, the EU Health Coalition (a group of 28 stakeholders from patient groups, research organisations and the pharmaceutical industry), calls the Council to increase Horizon Europe to €120 billion, ahead of their discussions on the Multiannual Financial Framework. Echoing the proposal from… read more
The European Commission published on the 12 June its 5th state-of-play communication on the preparation of contingency measures for the withdrawal of the United Kingdom from the European Union (Brexit). In its 10-page document, the Commission reiterates its recommendation for a high level of preparedness… read more
We would like to make you aware of an event chaired by EUCOPE Secretary General Alexander Natz which looks from various angles at innovative payment models in the UK, BeNeLuxAI, Italy and Germany. Speakers include, inter alia, Dr Diane Kleinermans, Ministry of Public Health and… read more
New improvements to the Accelerated Access Collaborative (AAC) will aim to put the most promising medicines, diagnostics, and digital services through the clinical development and regulatory approval process faster. The AAC was set up in 2018 as a fast-track route into the NHS for breakthrough… read more
With almost one year to go before the implementation of the Medical Devices Regulation (MDR) 2017/745, the Brussels-based edition of Politico reports on the main problems for related stakeholders, whilst the European Commission is scrambling to get things in order before May 2020. Representing EUCOPE… read more
You still have a bit more than one month to contribute to the EMA’s next strategy for regulatory science! The European Medicines Agency (EMA) is indeed seeking views from stakeholders, partners and the general public on its proposed strategy on Regulatory Science to 2025. By… read more
On 17 June 2019, the EU Commission (EC) will gather a large spectrum of stakeholders from the Member States, patients, academia, healthcare professionals and industry to collect their views on the successes and limitations of the regulatory framework for Paediatric medicines and Orphan Medicinal Products… read more
Our member MAP BioPharma recently put forward a series of recommendations focused on UK’s appraisals and reimbursement processes, in their latest publication titled Access to Orphan Medicines: A Case for Change. The report shows that: Very small differences between treatments in terms of patient numbers or… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View